Semaglutide and muscle loss
Table of Contents Section 1: Introduction Semaglutide, a revolutionary drug initially approved for the treatment of type 2 diabetes, has more recently garnered widespread attention for its efficacy in weight management and obesity treatment. As a glucagon-like peptide-1 (GLP-1) receptor agonist, semaglutide mimics the action of the GLP-1 hormone, which is naturally produced in the …